Infants born with cardiac abnormalities causing dependence on the arterial duct for pulmonary blood flow are often palliated with a shunt usually between the subclavian artery and either pulmonary artery. A so-called modified Blalock-Taussig shunt allows progress through early life to an age and weight at which repair or further more stable palliation can be safely achieved. Modified Blalock-Taussig shunts continue to present concern for postprocedural instability and early mortality such that other alternatives continue to be explored. Duct stenting (DS) is emerging as one such alternative with potential for greater early stability and improved survival.
B
abies born with complex cardiac abnormalities are not infrequently dependent on the arterial duct for pulmonary blood flow after birth. Patency of the arterial duct can be temporarily maintained with intravenous prostaglandins while preparations are made for surgical palliation with a shunt. The Blalock-Taussig-Thomas shunt has provided palliation for congenital heart disease since the initial description in 1944. 1 Other than the adoption of a Gore-Tex conduit to provide a predictably sized connection between the subclavian and pulmonary artery, the technical aspects of the procedure have remained largely unchanged over 70 years. 2 Although procedural mortality has significantly declined over time, it is still measurable and has driven consideration of alternative approaches. 3 This mortality results largely from early hemodynamic instability associated with diastolic runoff through the shunt and coronary artery steal. The competing alternative, first described in 1992, is a transcatheter approach to stent the arterial duct and to secure pulmonary blood flow. 4 Given the precarious conditions we seek to palliate, it is perhaps unsurprising that stenting the arterial duct is also associated with significant morbidity and mortality. 5 Consequently, neither procedure has emerged as superior, with preference tending to center around the chosen practice of individual programs. In the last few years, there have been an increase in the number of arterial duct stent (DS) procedures performed and an acceptance that the difficult experiences of the early procedures have resulted in some standardization of equipment and approach. [6] [7] [8] [9] It is timely and appropriate to seek to compare the 2 procedures given that appreciable early mortality continues to be reported for both.
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METHODS
Study Population and Design
This was a UK multicenter cohort study of all patients <30 days of age with a diagnosis of duct-dependent pulmonary blood flow undergoing as their first procedure either a modified Blalock-Taussig shunt (MBTS) or an arterial DS over a 4-year period (January 1, 2012, to December 31, 2015). Oneyear follow-up continued to December 31, 2016. Groups were assigned on an intention-to-treat basis; duct instrumentation regardless of whether a DS was successfully achieved was assigned to the DS group. All UK centers contribute to a mandatory validated prospective audit of cardiac surgical and intervention outcomes (National Congenital Heart Disease Audit), and 9 UK centers searched their audit to identify all cases that met these inclusion criteria. Written informed consent was obtained for inclusion in this audit, and individual center approvals were obtained for the study. The primary outcome was survival to next-stage surgery (either further palliation or repair), and secondary outcomes were survival to 30 days, discharge, and 1 year and need for postprocedural extracorporeal membrane oxygenation (ECMO). Other measures of interest included early hospital morbidity (duration of intensive care unit stay, need for postprocedural ventilation, and hospital stay), incidence of unintended interventions before next-stage surgery, need for pulmonary arterioplasty at next-stage surgery or repair, and prerepair pulmonary artery dimensions. DS procedural success was defined as stable pulmonary blood flow without the need for crossover to an MBTS.
Patient Details
Baseline demographics were investigated to explore the similarity of the 2 cohorts. Pulmonary artery imaging data before next-stage surgery were captured when available (angiography, computed tomography, or magnetic resonance imaging). Pulmonary artery dimensions were measured only if a reliable calibration factor was present, and measurements were made with digital calipers. The right and left pulmonary artery measurements were obtained between the shunt anastomosis or DS insertion and proximal to the upper lobe branch pulmonary artery. Given the relative frequency of stenotic lesions, the narrowest diameter was not necessarily recorded but rather the length of pulmonary artery most representative of the overall vessel diameter. Multiple measurements were obtained in 2 views, and the means were recorded. Pulmonary artery diameter was corrected for body surface area at the time of the procedure and by using the Nakata index 
Clinical Perspective
What Is New?
• Ductal stenting is a technically challenging procedure, and whether it can obviate the need for a modified Blalock-Taussig shunt needs to be established.
• Stenting the arterial duct is preferable over using a modified Blalock-Taussig shunt in terms of survival to next-stage surgery, early postprocedural hemodynamic stability, and shorter intensive care unit and hospital stays.
• There is a high failure rate both early, with inability to stent the duct, and late, with greater need for reintervention on the stented duct, compared with a modified Blalock-Taussig shunt.
What Are the Clinical Implications?
• Stenting the arterial duct remains an important and preferred option for palliation of neonates with dependence on the arterial duct for pulmonary blood flow.
• This needs to be in the context of a well-orchestrated follow-up program given the high likelihood of need to reintervene on the stented duct to provide a length of palliation similar to a modified Blalock-Taussig shunt.
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Surgical and Intervention Details
Modified Blalock-Taussig Shunt
The Gore-Tex shunt (W.L. Gore and Associates, Flagstaff, AZ) size was at the discretion of the surgeon, but generally, a 4-mm shunt was used for patients >3.5 to 4 kg and a 3.5-mm shunt was used for those <3.5 kg. The surgical approach was at the discretion of the surgeon. The pulmonary artery end was sewn to the distal main/right or left pulmonary artery depending on anatomy with a running suture. The aortic end was sutured to either the subclavian artery or the distal innominate artery with a similar technique.
DS Placement
Access varied depending on anatomy and operator preferences. The technique has become relatively standardized to 4F access followed by instrumentation of the duct with an 0.014-in coronary wire followed by placement of a coronary stent (mounted on a balloon between 3 and 5 mm). Some operators used a "buddy" wire to facilitate stent positioning, removing this wire before deployment. In the majority of cases, a 4F long sheath was used to provide stability and distal angiography during stent positioning. One or multiple stents were used to cover the length of the duct.
Statistical Analysis
Stata version 14.2 12 was used for all statistical analyses. Baseline and univariable comparisons were performed with a Mann-Whitney comparison of nonpaired samples (2 tailed) for continuous measures and a χ 2 test or Fisher exact test for categorical measures. Medians and interquartile ranges (IQRs) are given for numeric variables, and numbers and percentages of patients are given for categorical variables. A statistical significance level of P<0.05 is assumed. The presented P values were not adjusted for multiple comparisons.
A directed acyclic graph 13 was constructed to assess covariate causal relationships. The directed acyclic graph was assessed with the R package dagitty 14 and was found to be consistent with the data set. A propensity score 15, 16 was calculated with all confounding variables: age, weight, procedure (elective or emergency), antegrade pulmonary blood flow, single-ventricle status, and prematurity, ie, those variables that potentially affect both the exposure (shunt type) and the outcome (survival, ECMO or reintervention). The balancing property was satisfied within Stata, which uses a comparison-of-means approach. Because the propensity score cannot accommodate the effects of unmeasured variables, it is assumed that there are no missing variables with sizeable causal impacts. Although patients are clustered by UK center, a multilevel analysis would not be appropriate because random effects would not be robust with only 9 upper-level units; hence, the propensity score calculation includes the fixed effects of the centers attended. Sensitivity analysis compared the effect of including competing exposures within the calculation of the propensity score (in some instances, this can improve model precision). Single-level logistic regression analysis, including propensity score, was then performed for primary and secondary outcomes, and odds ratios are reported with 95% confidence intervals (CIs). A minimally sufficient adjustment set was identified from the directed acyclic graph, and a multivariable analysis that explicitly adjusted for each confounder was compared with the model that used the propensity score. Survival analysis was performed on the longer-term survival outcomes of mortality before repair and reintervention using Cox proportional hazards regression while accommodating the propensity score in the same manner as for the logistic regression analyses. Hazard ratios and 95% CIs are reported. 
RESULTS
Baseline Demographics
Over the study period . In the DS group, there were 17% failed procedures (procedural success, 82.9%) requiring conversion to an MBTS (n=13). Four were for failure to cross a tortuous duct and secure adequate wire position (although procedure attempted); in 2, the proximal duct was not covered; in 1, perforation of the right ventricle occurred; and in 1, the duct was dissected. One stent resulted in inadequate perfusion of the left pulmonary artery, and there were 4 early stent failures (occlusion, inadequate pulmonary blood flow, in-stent stenosis). A, Aortogram through a 4F long sheath positioned in the ascending aorta demonstrates the pulmonary artery anatomy and the insertion of the duct with restriction into the main pulmonary artery. Note the moderate left pulmonary artery narrowing, which is also seen in D and E. B, Two coronary wires (1 working wire and 1 "buddy" wire) are positioned in the right pulmonary artery through an internal mammary catheter in the proximal duct. C, The buddy wire is removed, and a coronary stent is positioned and deployed. The balloon is then removed before a repeat angiogram demonstrates good perfusion of both the right and left pulmonary vascular beds (D). E, Prerepair angiogram through a pigtail catheter in the transverse arch at 6 months of age demonstrates acceptable growth of both pulmonary arteries. The duct stent has remained widely patent. Table 2 shows the results of the multivariable analysis, accommodating propensity score, which was calculated from all confounding variables plus the fixed effects of the center attended. Patients in the DS group had an elevated odds of surviving before repair compared with patients in the MBTS group (odds ratio, 4.24; 95% CI, 1.37-13.14; P=0.012). Patients in the DS group had reduced odds of receiving postprocedural ECMO (odds ratio, 0.22; 95% CI, 0.05-1.05; P=0.058) compared with patients in the MBTS group. The inclusion of competing exposures in calculating propensity scores did not substantially affect the results, with no improvement in the precision of estimates of effect. Analysis of the minimally sufficient adjustment set identified by the directed acyclic graph gave results consistent with the propensity score analysis. Table 3 shows the results of the survival analysis on the 2 longer-term survival outcomes of mortality before repair or next-stage surgery and reintervention with adjustment for the propensity score. Patients in the DS group experienced a reduced risk of death before repair compared with patients in the MBTS group (hazard ratio, 0.25; 95% CI, 0.07-0.85; P=0.026). This supports the result seen for survival before repair in the multivariable analysis. Patients in the DS group had slightly increased odds of reintervention compared with patients in the MBTS group (hazard ratio, 1.50; 95% CI, 0.85-2.64; P=0.165). The proportional hazards assumption was met for each outcome. As with the multivariable analysis, the inclusion of competing exposures in calculating the propensity score did not alter the findings. The analysis of reintervention with the minimally sufficient adjustment set differed modestly from that using the propensity score (hazard ratio, 1.96; 95% CI, 1.06-3.61; P=0.031). In the MBTS group, the majority of interstage reintervention was the need for early shunt revision or change to another source of pulmonary blood flow (11 of 15 early interventions; right ventricle to pulmonary artery conduit or transannular patch) alongside later stenting of the shunt to provide a greater period of palliation (14 of 24 late interventions). In the DS group, apart from the early procedural failures that crossed over to the MBTS group, interventions occurred predominantly late (23 of 30, including 14 procedures to restent or balloon the existing DS). Figures 3 and 4 show Kaplan-Meier curves comparing survival and reintervention in patients across the 2 groups before repair or next-stage surgery.
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Multivariable Analysis of Primary and Secondary Outcome Measures
Survival Analysis of Longer-Term Outcomes
Hospital and Procedural Morbidity
The DS group had a shorter length of stay, shorter intensive care unit stay, and fewer ventilation days (Table 4) .
Pre-Next-Stage Surgery Variables
The DS group came to next-stage palliative surgery or complete repair at a median age of 246 days (IQR, 176-393 days) compared with the MBTS group at a median age of 254 days (IQR, 172-356 days; P=0.954). Oxygen saturations and weight at this time point were similar across the 2 groups ( in the DS group; P=0.027). Destination surgical procedures performed were similar (Table III in 
DISCUSSION
Even in the current era, Blalock-Taussig shunts are associated with 30-day mortality rates far in excess of many more technically complex neonatal operations. 17 Postoperative instability after MBTS with associated morbidity and mortality has resulted in a drive toward early neonatal repair when technically possible, alongside alternative approaches to secure pulmonary blood flow when the possibility of repair does not exist. 18, 19 In the context of avoiding high-risk shunting, DS has increased in prevalence over recent years as an alternative palliation in this patient group. This study analyzes and compares the outcomes of DS and surgical shunting in patients with duct-dependent pulmonary blood flow in a large, unselected, prospectively collected contemporary series. This study clearly demonstrates a survival advantage with DS through destination surgical therapy (either repair or next-stage palliation). It also demonstrates greater stability after the procedure with less need for postoperative ECMO.
Although published studies have suggested that DS is an alternative to a surgical shunt, comparisons of outcomes have been limited to much smaller single-center series and consequently further limited by the enthusiasm of a given institution for a particular approach. 5, 20 Advantages and disadvantages of either approach have been difficult to demonstrate.
These results are partly tempered by procedural success (83% for SD, with 17% of the group requiring an early MBTS for procedural failure). Although equipment has improved substantially since the early descriptions of the 
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technique, complex duct anatomy remains a significant technical challenge. 4 In addition, reintervention in the interstage period is an important issue, with 39.8% of the DS group requiring additional procedures before nextstage surgery as opposed to only 24.0% of the MBTS group. Reintervention rates in this study are not significantly different from other published single-center case series, 20 and it seems likely that achieving the length of palliation required (median, 243 days for MBTS and 231 days for DS) comes at the cost of further transcatheter treatments in a significant proportion of patients. With this approach, good palliation can be achieved, with infants receiving DS generally coming to next-stage surgery at a similar age, weight, oxygen saturation, hemoglobin, and pulmonary artery dimensions as infants after MBTS.
In the absence of randomization, the major limitation and criticism for discussion is whether the 2 groups really are similar. The 2 groups reflect national UK practice, are demonstrably well matched at baseline, and continue to remain so throughout the study (diagnosis, single-ventricle status, and next-stage surgery performed). However, lack of randomization is a legitimate concern. Observational analyses of this nature fail to fully account for selection bias subtly and inadvertently introduced into the study, which cannot be controlled. A simple example of selection of unknown significance would be interventionists choosing cases with echocardiographically indicated straighter ductal courses given the higher likelihood of successful stenting. The only way to account for these factors is to perform a randomized trial of a magnitude and design similar to the single-ventricle reconstruction trial that compared shunt types in the Norwood procedure. 21 It should also be noted that assumptions and caveats are inherent within statistical analyses and that alternative analyses could have been performed on the given data. The results presented here are those we believe to be the most appropriate for the available data. Effect sizes may be mitigated or attenuated should other approaches be used.
The main strength of this study is that it brings to the fore a national comparison of these 2 approaches. Given the results presented here, a reasoned approach would be to offer DS to all cases in need of secure pulmonary blood flow regardless of duct morphology. We have seen no evidence that crossover from the DS to an MBTS results in a survival disadvantage in cases when there was failure to successfully stent the duct. These infants, however, are likely to benefit from close follow-up given the high likelihood of need for reintervention before they reach an age or weight to proceed with nextstage surgery. A cost comparison of these 2 approaches is beyond the scope of this study but is achievable with the data presented. Less need for ECMO, shorter intensive care unit stay with less need for ventilation, and shorter overall hospital stay need to be balanced against greater need for reintervention in the DS group.
Is stenting the arterial duct superior to a Blalock shunt? In this study, the first to assess the 2 competing procedures side by side across multiple centers, there are still twice as many shunts performed as DSs. In the 25 years since the procedure was first described, DS cannot be regarded as a panacea of palliation, but we have demonstrated that it can safely be considered as a preferred alternative. This article offers centers confidence that this procedure has tangible advantages over an arterial shunt, particularly in relation to early postprocedural stability, but the quest for truly excellent palliation remains.
CONCLUSIONS
Stenting the arterial duct to secure pulmonary blood flow in infants with duct-dependent congenital heart disease appears to offer early survival advantage and improved early hemodynamic stability over a surgical arterial shunt. This is at the expense of procedural failure in a proportion of patients and increased likelihood of reintervention in the interstage period.
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